Stocks / NASDAQ / CoLucid Pharmaceuticals, Inc.

CoLucid Pharmaceuticals, Inc.

Industry:   Health Care - Major Pharmaceuticals Stock Symbol:   CLCD - NASDAQ Animal Usage:   No Animal Exploitation

Company Description

CoLucid Pharmaceuticals, Inc. is a Phase III clinical-stage biopharmaceutical company. The Company is engaged in developing a small molecule for the acute treatment of migraine headaches. Its product candidates address the needs of migraine patients, including those with cardiovascular risk factors or stable cardiovascular disease and those dissatisfied with existing therapies. Lasmiditan, the Company’s lead product candidate, is an oral tablet for the acute treatment of migraine in adults. The Company is conducting its Phase III randomized, double-blind, placebo-controlled clinical trial of lasmiditan. [Source: GoogleFinance]

Company Website: https://www.lilly.com

Contact:   https://www.lilly.com/contact-page;